Back to Journals » Biologics: Targets and Therapy » Volume 12

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection

Total article views   Abstract views HTML views PDF downloads Totals
9,492 Dovepress* 4,786 765+ 988 5,551
PubMed Central* 0 3,941 542 3,941
Totals 4,786 4,706 1,530 9,492
*Since 18 January 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 3 4

View citations on PubMed Central and Google Scholar